학술논문
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
Document Type
Artikel
Author
Oaknin, A; Gladieff, L; Martinez-Garcia, J; Villacampa, G; Takekuma, M; De Giorgi, U; Lindemann, K; Woelber, L; Colombo, N; Duska, L; Leary, A; Godoy-Ortiz, A; Nishio, S; Angelergues, A; Rubio, MJ; Farinas-Madrid, L; Yamaguchi, S; Lorusso, D; Ray-Coquard, I; Manso, L; Joly, F; Alarcon, J; Follana, P; Romero, I; Lebreton, C; Perez-Fidalgo, JA; Yunokawa, M; Dahlstrand, H; D'Hondt, V; Randall, L
Source
Lancet (London, England). 403(10421):31-43
Subject
Language
English
English
English
ISSN
1474-547X